Flagship to Invest £100 Million in AI-Driven Drug Companies in Britain
Venture firm Flagship plans to invest £100 million to build AI-driven drug companies in Britain. The body is truncated after “First lab for c”.
Venture firm Flagship plans to invest £100 million to build AI-driven drug companies in Britain. The body is truncated after “First lab for c”.